BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 137854)

  • 1. [Pharmaco-kinetic investigations of a new gall bladder contrast medium--iodoxaminic acid (author's transl)].
    Mähner B; Krüger R; Siehr U; Wilhelmi U
    Rofo; 1976 Dec; 125(6):556-9. PubMed ID: 137854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and plasma albumen binding of iotroxic acid (Biliscopin), iodoxic acid (Endomirabil) and ioglycamine (Biligram) (author's transl)].
    Taenzer V; Speck U; Wolf R
    Rofo; 1977 Mar; 126(3):262-7. PubMed ID: 139346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the biliary excretion of the hepatotropic contrast media ioglycamate and iotroxinate in pigs and men (author's transl)].
    Klapdor R; Aban Y; Sepehr H; Scherer K
    Rontgenblatter; 1978 Feb; 31(2):114-9. PubMed ID: 635378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Animal experiments on the distribution and excretion of an intravenously injected biliary contrast medium (Ioglycomate) (author's transl)].
    Hilweg D
    Rofo; 1976 Apr; 124(4):320-7. PubMed ID: 131756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemical structure biliary excretion of iodine-containing contrast agents in hemoglobin-free perfused rat liver and in vivo (author's transl)].
    Azuma H; Oshino N
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(5):321-32. PubMed ID: 7203274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous cholegraphy with Chologram (a double blind comparison with Bilivistan) (author's transl)].
    Taenzer V; Blumenbach L; Heitzeberg H; Kolb KH; Speck U; Wolf R
    Rofo; 1975 Nov; 123(5):414-8. PubMed ID: 128498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of maximum transport of a new contrast medium for intravenous cholangiography].
    Juliani G; Gaia E; Mariani E
    J Radiol Electrol Med Nucl; 1975; 56 suppl 1():42-4. PubMed ID: 1243919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tolerance and contrast density in intravenous cholangiography and cholecystography using a new contrast medium (author's transl)].
    Siemers M; Schäfer K; Menges G; Horst H
    Rontgenblatter; 1978 Oct; 31(10):596-9. PubMed ID: 581525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)].
    Schmerwitz W; Rösch E
    Rontgenblatter; 1977 Feb; 30(2):71-8. PubMed ID: 576505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].
    Kölling K; Hoenle R; Korsten FW
    Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with iodoxamic acid in the cholecystography-cholangiography (author's transl)].
    Keiner F
    Med Klin; 1976 Oct; 71(44):1885-90. PubMed ID: 1036604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of contrast volume on the radiographic demonstration of the gall bladder and bile duct (author's transl)].
    Heep H; Abt K; Strnad R; Klemencic J; Wegwitz J
    Rofo; 1979 Apr; 130(4):420-2. PubMed ID: 155595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion of iodipamide and iodoxamate in normal and common bile duct-obstructed dogs.
    Burgener FA; Fischer HW; Denyon TD
    Invest Radiol; 1978; 13(3):255-63. PubMed ID: 581381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiographic excretion studies: a comparison of iodipamide and iodoxamate in the dog.
    Evill CA; Benness GT
    Invest Radiol; 1976 SEP-OCT; 11(5):459-63. PubMed ID: 989759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies regarding a new contrast medium for demonstrating the patency of bile ducts (author's transl)].
    Krueger P; Fries HH
    Rontgenblatter; 1976 Nov; 29(11):540-3. PubMed ID: 1013630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigations on the retention period and tolerance of Hexabrix as x-ray contrast medium in arthrography (author's transl)].
    Loeffler K; Klose-Violette D; Brehm H
    Rontgenblatter; 1982 Apr; 35(4):151-4. PubMed ID: 7079664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Linear and non linear models of the kinetics of biliotropic contrast media].
    Segre G; Rosati GF
    J Radiol Electrol Med Nucl; 1975; 56 suppl 1():44-7. PubMed ID: 1243920
    [No Abstract]   [Full Text] [Related]  

  • 18. Gall-bladder and colonic opacification following parenteral ioxaglate.
    Udeshi UL
    Clin Radiol; 1985 Sep; 36(5):497-8. PubMed ID: 4075720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and biotransformation of iohexol in the rat and the dog.
    Mützel W; Speck U
    Acta Radiol Suppl; 1980; 362():87-92. PubMed ID: 6267898
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of the biliary excretion of the radiographic contrast media Iotroxamate and Ioglycamide in the dog].
    Grandjean EM; Zaunbauer W; Paumgartner G; Fuchs WA
    Schweiz Med Wochenschr; 1978 Jul; 108(28):1073-5. PubMed ID: 675198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.